Ovid Therapeutics (OVID) Assets (2016 - 2026)
Ovid Therapeutics (OVID) reported Assets of $231.97 million for Q2 2026, up 199.6% from $77.43 million a year earlier and up 2.8% from the prior quarter.
Powered by 
Analysis
Ovid Therapeutics (OVID) Assets (2016 - 2026) Analysis & Trends
At the end of FY2025, Ovid Therapeutics posted Assets of $150.93 million, up 63.8% from FY2024.
- Assets has a five-year compound annual growth rate of 14.7% (FY2020 to FY2025).
- By year, Assets came in at $92.17 million in FY2024 (-36.0%), $144.03 million in FY2023 (-7.2%), $155.27 million in FY2022 (-20.2%) and $194.54 million in FY2021 (+156.2%).
- The Q2 2026 figure ranks as the highest quarterly Assets since Q1 2021.
- Year over year, Assets has now increased in each of the last three quarters, with growth averaging 34.4% over the last eight quarters.
- The high point for year-over-year Assets in five years was Q2 2026 (growth of 199.6%); the low point was Q1 2025 (a decline of 38.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $225.63 million (Q1 2026), $150.93 million (Q4 2025) and $63.85 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Ovid Therapeutics | 454.50 Mn | 86.52 Mn | - | 231.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 231.97 Mn |
| Mar 31, 2026 | 225.63 Mn |
| Dec 31, 2025 | 150.93 Mn |
| Sep 30, 2025 | 63.85 Mn |
| Jun 30, 2025 | 77.43 Mn |
| Mar 31, 2025 | 81.65 Mn |
| Dec 31, 2024 | 92.17 Mn |
| Sep 30, 2024 | 102.65 Mn |
| Jun 30, 2024 | 118.09 Mn |
| Mar 31, 2024 | 131.61 Mn |
| Dec 31, 2023 | 144.03 Mn |
| Sep 30, 2023 | 125.03 Mn |
| Jun 30, 2023 | 136.23 Mn |
| Mar 31, 2023 | 143.37 Mn |
| Dec 31, 2022 | 155.27 Mn |
| Sep 30, 2022 | 165.03 Mn |
| Jun 30, 2022 | 177.33 Mn |
| Mar 31, 2022 | 191.10 Mn |
| Dec 31, 2021 | 194.54 Mn |
| Sep 30, 2021 | 207.09 Mn |
API Access
Ovid Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=OVID&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "OVID", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=OVID&period=max&api_key=YOUR_API_KEY");
const data = await res.json();